Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complex chronic comorbidities of COPD.

L M Fabbri1, F Luppi, B Beghé

  • 1Dept of Oncology, Haematology and Respiratory Diseases, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy. fabbri.leonardo@unimore.it

The European Respiratory Journal
|January 2, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndrome.

Nature communications·2025
Same author

Bronchiectasis as long-term complication of acute fire smoke inhalation?

Pulmonology·2023
Same author

Increased breath naphthalene in children with asthma and wheeze of the All Age Asthma Cohort (ALLIANCE).

Journal of breath research·2023
Same author

[German S1 Guideline Long-/Post-COVID].

Pneumologie (Stuttgart, Germany)·2022
Same author

Work-related interstitial lung diseases: reassessing the burden.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Prevalence of asthma and COPD in a cohort of patients at the follow up after COVID-19 pneumonia.

Pulmonology·2022
Same journal

Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing.

The European respiratory journal·2026
Same journal

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same journal

Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.

The European respiratory journal·2026
Same journal

Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertension.

The European respiratory journal·2026
Same journal

Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

The European respiratory journal·2026
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
See all related articles

Chronic obstructive pulmonary disease (COPD) involves lung inflammation and systemic inflammation from smoking. This systemic inflammation links COPD to heart failure and metabolic syndrome, requiring complex patient care.

Area of Science:

  • Pulmonary Medicine
  • Cardiology
  • Systemic Inflammation Research

Background:

  • Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation and inflammation due to cigarette smoke.
  • Smoking-induced systemic inflammation contributes to COPD's progression and is linked to other chronic conditions like heart failure and metabolic syndrome.
  • COPD is increasingly recognized as a systemic disease with widespread health implications beyond the lungs.

Purpose of the Study:

  • To highlight the systemic nature of COPD and its associated comorbidities.
  • To emphasize the need for a holistic approach in diagnosing and managing COPD patients.
  • To advocate for integrating assessments of systemic inflammation and comorbidities into COPD care.

Main Methods:

  • Review of current understanding of COPD pathophysiology, focusing on systemic inflammation.

Related Experiment Videos

  • Analysis of the impact of comorbidities on COPD diagnosis and severity assessment.
  • Proposal for enhanced patient characterization using lung function, cardiovascular/metabolic assessments, and inflammatory markers.

    • Main Results:

    • COPD is not solely a lung disease but involves significant systemic inflammation.
    • Systemic inflammation contributes to comorbidities such as chronic heart failure and metabolic syndrome.
    • Comorbidities significantly influence COPD's clinical presentation and natural course.

    Conclusions:

    • COPD management must evolve beyond lung-centric approaches to encompass systemic effects and comorbidities.
    • Comprehensive patient assessment, including systemic markers, is crucial for accurate COPD characterization.
    • Integrated therapeutic strategies addressing the complexity of COPD patients are essential for improved outcomes.